Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Haddock, Andrew James
Steinke, G. Karl
Serrano Carmona, Raul Enrique
Abrégé
This document discusses a computer-implemented method of operating a neurostimulation device to deliver electrical neurostimulation when connected to an implantable stimulation lead. The method includes delivering neurostimulation to a subject using a neurostimulation device of the neurostimulation system when the neurostimulation device is connected to an implantable stimulation lead; recording electrical signals sensed using the implantable stimulation lead; detecting and correcting errors in a recorded electrical signal to produce a corrected recorded electrical signal; and adjusting a device-based neurostimulation therapy provided to the subject using the corrected recorded electrical signal.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
2.
Use of Brain Anatomical Features to Optimize Deep Brain Stimulation
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Juárez Paz, León M.
Carcieri, Stephen
Abrégé
Methods and systems for assisting the programming of stimulation parameters for deep brain stimulation (DBS) for a subject patient are described. An accumulated database comprises data from a plurality of historical fitting/programming sessions. The data can include various stimulation parameter sets that were tried for patients in the database; data relating to the position of the electrode lead with respect to anatomical features the patients' brains, for example, with respect to the alignment of their subthalamic nucleus (STN); scores indicating the therapeutic effectiveness of the stimulation parameters; and data relating to stimulation field models (SFMs) for the various stimulation parameter sets. The database may be used to predict stimulation parameter sets that are likely to be therapeutically effective for the subject patient.
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 30/20 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le maniement d’images médicales, p. ex. DICOM, HL7 ou PACS
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Huynh, Dat Thanh
Mcdonald, Matthew Lee
Hershey, Bradley Lawrence
Lechleiter, Kristen Marie
Woon, Rex James
Abrégé
Various embodiments of the present subject matter use health-related information to improve the monitoring and treatment provided to remotely managed patient populations by generating patient states to simplify the triaging of patient conditions. In an example, the system can monitor and analyze data, and can include identifying a first patient state from among a plurality of patient states, the plurality of patient states being defined by a state-based goal classification; identifying a second patient state from the plurality of patient states; capturing a change in patient state; and providing a monitoring platform to monitor the change in the patient state. In further examples, adaptive measures can be implemented to account for missing or withheld patient-related data used to generate patient states.
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Huynh, Dat Thanh
Mcdonald, Matthew Lee
Hershey, Bradley Lawrence
Lechleiter, Kristen Marie
Woon, Rex James
Abrégé
Various embodiments of the present subject matter use health-related information to improve the monitoring and treatment provided to remotely managed patient populations by generating patient states to simplify the triaging of patient conditions. In an example, the system can receive from a user via. a user interface, criteria related to one or more goals to accomplish while receiving therapy to treat a condition. The system can translate, by at least one hardware processor, the criteria related to the one or more goals to a state-based classification defining a plurality of patient states defined by a plurality of parameters and receive a. first set of parameter values. The system can further identify a first patient state from among the plurality of patient states using the first set of parameter values and generate an output including the first patient state.
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
5.
ENHANCED DATA CORRECTION IN SENSED NEUROMODULATION APPLICATIONS
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Haddock, Andrew James
Steinke, G. Karl
Serrano Carmona, Raul Enrique
Abrégé
This document discusses a computer-implemented method of operating a neurostimulation device to deliver electrical neurostimulation when connected to an implantable stimulation lead. The method includes delivering neurostimulation to a subject using a neurostimulation device of the neurostimulation system when the neurostimulation device is connected to an implantable stimulation lead; recording electrical signals sensed using the implantable stimulation lead; detecting and correcting errors in a recorded electrical signal to produce a corrected recorded electrical signal; and adjusting a device-based neurostimulation therapy provided to the subject using the corrected recorded electrical signal.
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G06F 11/00 - Détection d'erreursCorrection d'erreursContrôle de fonctionnement
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
6.
METHOD AND APPARATUS FOR USING STIMULATION AND SENSING DISTANCES IN NEUROSTIMULATION CONTROL
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moffitt, Michael A.
Abrégé
A neurostimulation system may include a stimulation output circuit to deliver neurostimulation pulses using a stimulation electrode positioned at a stimulation distance from a neural target, a sensing circuit to sense neural signals using a sensing electrode positioned at a sensing distance from the neural target, and a stimulation control circuit that may include a test controller and a test processor. The test controller may be configured to control performance of an electrode distance test including sensing a first neural signal of the neural signals using the sensing electrode while delivering the neurostimulation pulses using the stimulation electrode and sensing a second neural signal of the neural signals using the stimulation electrode while delivering the neurostimulation pulses using the sensing electrode. The test processor may be configured to analyze the stimulation and sensing distances using the first and second neural signals.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
7.
CONTEXT-DEPENDENT WEIGHTING FOR CLOSED-LOOP NEUROMODULATION TREATMENT
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Hershey, Bradley Lawrence
Abrégé
Systems and techniques are disclosed to adapt neurostimulation programming in closed-loop adjustment of an implantable neurostimulation device, based on evaluation and weighting of patient data that excludes or reduces effects of interfering events. In an example, adapting a neurostimulation programming model includes: obtaining patient data observed during a prior time period; identifying events experienced by the patient during the prior time period (e.g., confounding events, intervention events) that cause variance in measurements of patient data; determining weighted data by weighting patient data observed during the one or more events, as the weighting of the patient data reduces effects of the patient data during the one or more events on a modification of the programming model; and modifying (e.g., re-training, reinforcing, or adapting) the programming model based on the weighted data. The modified programming model can then be used to generate updated programming parameters for subsequent neurostimulation treatment.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
8.
Likelihood Determination of Stimulation Provoked Side Effects Regions in Deep Brain Stimulation
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Juárez Paz, León M.
Abrégé
Methods and systems for assisting the programming of stimulation parameters for deep brain stimulation (DBS) for a subject patient are described. An accumulated database comprises data from a plurality of historical fitting/programming sessions. The data can include various stimulation parameter sets that were tried for patients in the database; data relating to the position of the electrode lead with respect to anatomical features the patients' brains, for example, with respect to the alignment of their subthalamic nucleus (STN); scores indicating the therapeutic effectiveness of the stimulation parameters and/or stimulation parameters that lead to side effects in the patients; and data relating to stimulation field models (SFMs) for the various stimulation parameter sets. The database may be used to predict stimulation parameter sets that are likely to be therapeutically effective or to cause side effects for the subject patient.
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Juárez Paz, León M.
Abrégé
Methods and systems for assisting the programming of stimulation parameters for deep brain stimulation (DBS) of a subject patient are described. An accumulated database catalogues stimulation parameter sets used in programming sessions for a plurality of patients and correlates the parameter sets with good therapeutic results and/or with side effects. The accumulated database also includes stimulation field models (SFMs) for the parameter sets. Overlap of the SFMs for parameter sets may be correlated with therapeutic effects and used to determine target volumes and or avoidance volumes for the stimulation of the subject patient. In some embodiments, the SFMs may be weighted to de-emphasize volumes proximate to the electrode lead.
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moore, Lisa Denise
Steinke, G. Karl
Abrégé
Systems and methods for state determination and normalization using adaptive neuromodulation based on biopotentials and/or electrophysiology (e.g., evoked responses) are disclosed. An exemplary system comprises at least one lead, an electrostimulator to provide electrostimulation to a neural target, a sensing circuit to sense ERs to electrostimulation, and a controller circuit. In response to electrostimulation delivered to the neural target in accordance with a stimulation setting via a stimulating electrode, the controller circuit may collect sensed ERs to the electrostimulation using at least one sensing electrode. The controller circuit may determine at least one parameter associated with the electrostimulation or an affect of the electrostimulation to the neural target. The controller circuit may associate at least one feature of a first set of the sensed ERs with the parameter to classify the parameter.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Huynh, Dat Thanh
Mcdonald, Matthew Lee
Hershey, Bradley Lawrence
Lechleiter, Kristen Marie
Woon, Rex James
Abrégé
Various embodiments of the present subject matter use health-related information to improve the monitoring and treatment provided to remotely managed patient populations by generating patient states to simplify the triaging of patient conditions. In an example, the system can monitor and analyze data, and can include identifying a first patient state from among a plurality of patient states, the plurality of patient states being defined by a state-based goal classification; identifying a second patient state from the plurality of patient states; capturing a change in patient state; and providing a monitoring platform to monitor the change in the patient state. In further examples, adaptive measures can be implemented to account for missing or withheld patient-related data used to generate patient states.
G16H 40/20 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion ou l’administration de ressources ou d’établissements de soins de santé, p. ex. pour la gestion du personnel hospitalier ou de salles d’opération
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Huynh, Dat Thanh
Mcdonald, Matthew Lee
Hershey, Bradley Lawrence
Lechleiter, Kristen Marie
Woon, Rex James
Abrégé
Various embodiments of the present subject matter use health-related information to improve the monitoring and treatment provided to remotely managed patient populations by generating patient states to simplify the triaging of patient conditions. In an example, the system can receive from a user via a user interface, criteria related to one or more goals to accomplish while receiving therapy to treat a condition. The system can translate, by at least one hardware processor, the criteria related to the one or more goals to a state-based classification defining a plurality of patient states defined by a plurality of parameters and receive a first set of parameter values. The system can further identify a first patient state from among the plurality of patient states using the first set of parameter values and generate an output including the first patient state.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
13.
STATE DETERMINATION AND NORMALIZATION USING SENSED SIGNALS
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Moore, Lisa Denise
Steinke, G. Karl
Abrégé
Systems and methods for state determination and normalization using adaptive neuromodulation based on biopotentials and/or electrophysiology (e.g., evoked responses) are disclosed. An exemplary system comprises at least one lead, an electrostimulator to provide electrostimulation to a neural target, a sensing circuit to sense ERs to electrostimulation, and a controller circuit. In response to electrostimulation delivered to the neural target in accordance with a stimulation setting via a stimulating electrode, the controller circuit may collect sensed ERs to the electrostimulation using at least one sensing electrode. The controller circuit may determine at least one parameter associated with the electrostimulation or an affect of the electrostimulation to the neural target. The controller circuit may associate at least one feature of a first set of the sensed ERs with the parameter to classify the parameter.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Carbunaru, Rafael
Moffitt, Michael A.
Bokil, Hemant
Esteller, Rosana
Marnfeldt, Goran N.
Rivera, John
Bocek, Joseph M.
Abrégé
A system may include a training system configured for training or improving a nervous system by responding to an event. The training system may include a neuromodulator configured for delivering neuromodulation to a nervous system, an event detector configured for detecting the event and sending a signal to the neuromodulator when the event is detected, and a timer configured for timing a predefined time period after receiving the signal. The neuromodulator may be configured to change neuromodulation to the nervous system at the end of the time period. The predefined time period may be a programmable time period in some embodiments.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
15.
HERMETIC CONNECTOR STACKS FOR AN ELECTRICAL STIMULATION SYSTEM
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Lopez, Thomas Paul
Amundson, Samuel N
Abrégé
A connector stack includes a plurality of conductive rings and a plurality of insulator rings. The plurality of insulator rings separating the conductive rings from each other. The plurality of conductive rings and the plurality of insulator rings form the connector stack, and define a lumen therethrough. The plurality of conductive rings and the plurality of insulator rings are brazed together such that the connector stack is a hermetically sealed stack. The conductive rings have one or more of a counterbore design, a conical design, or a D-flat profile. The insulator rings may be disk shaped or may have a shape similar to the conductive rings.
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Carbunaru, Rafael
Moffitt, Michael A.
Bokil, Hemant
Esteller, Rosana
Marnfeldt, Goran N.
Rivera, John
Bocek, Joseph M.
Abrégé
A system may include a training system configured for training or improving a nervous system by responding to an event. The training system may include a neuromodulator configured for delivering neuromodulation to a nervous system, an event detector configured for detecting the event and sending a signal to the neuromodulator when the event is detected, and a timer configured for timing a predefined time period after receiving the signal. The neuromodulator may be configured to change neuromodulation to the nervous system at the end of the time period. The predefined time period may be a programmable time period in some embodiments.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
17.
EVOKED RESPONSE-GUIDED MULTISITE DEEP BRAIN STIMULATION
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Steinke, G. Karl
Abrégé
Systems and methods for providing evoked response-guided multisite deep brain stimulation (DSB) at various brain targets are disclosed. An exemplary system comprises at least one multi el ectrode lead, an electrostimulator to provide electrostimulation to a neural target, a sensing circuit to sense an evoked response (ER) to electrostimulation, and a controller circuit. In response to electrostimulation of a first neural target according to a first stimulation setting, the controller circuit collects an ER from a first sensing location, and determines or adjusts a second stimulation setting for stimulating a second neural target based on the sensed ER at the first neural target. The second neural target can be stimulated according to the second stimulation setting to modulate the ER to the electrostimulation at the first neural target, and to produce a desired therapeutic outcome in the patient.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
18.
SIDE EFFECT PREDICTION AND EVALUATION FOR NEUROSTIMULATION TREATMENTS
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Moore, Lisa Denise
Hoenes, Benjamin Ray
Juarez Paz, Leon Mauricio
Malekmohammadi, Mahsa
Abrégé
Systems and techniques are disclosed to identify and monitor side effects and treatment outcomes relating to neurostimulation programming. An example technique to identify a side effect relating to neurostimulation programming includes: obtaining neurostimulation programming parameters to be used in a neurostimulation device of a patient; obtaining source data that defines effects of neurostimulation treatment in an anatomical area of the patient; modeling use of the neurostimulation programming parameters in the anatomical area of the neurostimulation treatment, based on the source data, to determine a predicted side effect; and outputting information that identifies characteristics of the predicted side effect.
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Lopez, Thomas Paul
Amundson, Samuel N
Abrégé
A connector stack includes a plurality of conductive rings and a plurality of insulator rings. The plurality of insulator rings separating the conductive rings from each other. The plurality of conductive rings and the plurality of insulator rings form the connector stack, and define a lumen therethrough. The plurality of conductive rings and the plurality of insulator rings are brazed together such that the connector stack is a hermetically sealed stack. The conductive rings have one or more of a counterbore design, a conical design, or a D-flat profile. The insulator rings may be disk shaped or may have a shape similar to the conductive rings.
A61N 1/375 - Aménagements structurels, p. ex. boîtiers
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Gururaj, Kiran K.
Wagenbach, David M.
Weiss, Philip L.
Feldman, Emanuel
Abrégé
Techniques for sensing neural responses such as Evoked Compound Action Potentials (ECAPs) in an implantable stimulator device are disclosed. A first therapeutic pulse phase is followed by a charge recovery phase that includes at least one high-impedance passive charge recovery duration. The ECAP is sensed during the high-impedance passive charge recovery duration.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/388 - Études de la conduction nerveuse, p. ex. détection du potentiel d’action d’un nerf périphérique
A61N 1/02 - ÉlectrothérapieCircuits à cet effet Parties constitutives
21.
EVOKED RESPONSE-GUIDED MULTISITE DEEP BRAIN STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Steinke, G. Karl
Abrégé
Systems and methods for providing evoked response-guided multisite deep brain stimulation (DSB) at various brain targets are disclosed. An exemplary system comprises at least one multielectrode lead, an electrostimulator to provide electrostimulation to a neural target, a sensing circuit to sense an evoked response (ER) to electrostimulation, and a controller circuit. In response to electrostimulation of a first neural target according to a first stimulation setting, the controller circuit collects an ER from a first sensing location, and determines or adjusts a second stimulation setting for stimulating a second neural target based on the sensed ER at the first neural target. The second neural target can be stimulated according to the second stimulation setting to modulate the ER to the electrostimulation at the first neural target, and to produce a desired therapeutic outcome in the patient.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
22.
AUTOMATING DATA DOWNLOAD IN A SYSTEM REQUIRING RESPONSIVENESS TO A SECONDARY CONTROL UNIT
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moore, Lisa Denise
Shah, Chirag
Serrano Carmona, Raul Enrique
Abrégé
A system for regulating data downloads from an implantable pulse generator (IPG) includes an IPG configured to download data, receive signals, and provide electrical stimulation, and an external device configured to initiate a data download from the IPG and to direct the IPG to download the data for a first time period. The IPG and/or external device is configured to stop the data download after the first time period has expired and to wait a first time interval during which no data is downloaded and the IPG is available to receive signals from any external control devices. The IPG and/or external device is configured to initiate an additional data download from the IPG to the external device for a second time period after the first time interval has expired, and to repeat the steps until all data has been downloaded from the IPG to the external device.
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Zhang, Tianhe
Thio, Brandon
Abrégé
A system for delivering neurostimulation to a patient may include a personalization circuit and a pattern optimization circuit. The personalization circuit may include an assessment input to receive patient-specific information resulting from a patient survey, a calibration input configured to receive calibration information resulting from a calibration, and personalization processing circuitry. The patient-specific information may include patient dimensions of the neurostimulation. The calibration information may include the patient's response to the neurostimulation. The personalization processing circuitry may be configured to determine a personalized objective function using the patient dimensions and to determine a personalized model having a model state personalized to the patient's response to the neurostimulation. The pattern optimization circuit may be configured to determine optimal pattem(s) of neurostimulation using the personalized objective function and the personalized model for programming a stimulation device to deliver the neurostimulation according to the optimal pattern(s) of neurostimulation.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
24.
PARAMETERIZING TECHNIQUES FOR SUB-PERCEPTION AND PARESTHESIA THERAPY
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Haddock, Andrew James
Esteller, Rosana
Abrégé
A system for closed-loop control of sub-perception spinal cord stimulation therapy is provided. The system includes an implantable pulse generator (IPG) with an evoked compound action potential (ECAP) recording module and accelerometer. A regression model maps accelerometer data to optimal stimulation parameters for consistent nerve activation. This enables closed-loop therapy in the sub-perception domain where ECAP features are not visually detectable. A clinician programmer applies the model and sub-perception dose to therapy programs deployed to the IPG. The model can be customized to each patient by collecting ECAP and accelerometer data. The mapping reconciles ECAP -based control between perception and sub-perception domains by supplementing unavailable ECAP data with accelerometer data. This improves stimulation therapies for patients receiving sub-perception and multi-sensor paresthesia treatments.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61B 5/24 - Détection, mesure ou enregistrement de signaux bioélectriques ou biomagnétiques du corps ou de parties de celui-ci
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
25.
SYSTEMS AND METHODS FOR MODULATING THE NEUROIMMUNE SYSTEM
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Gu, Jianwen
Hershey, Bradley Lawrence
Zhu, Changfang
Abrégé
Methods and systems for modulating the neuroimmune response while monitoring biomarkers that may directly or indirectly correlate with neuroimmune function. A neuromodulation therapy may be delivered, and a biomarker level determined. Some biomarker levels are determined from bodily fluid collected from the patient, and are compared to a predetermined threshold level. A therapeutic stimulation is delivered to a patient using one or more electrode leads, and/or optical fibers.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1459 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61N 5/06 - Thérapie par radiations utilisant un rayonnement lumineux
26.
AUTOMATING DATA DOWNLOAD IN A SYSTEM REQUIRING RESPONSIVENESS TO A SECONDARY CONTROL UNIT
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Moore, Lisa Denise
Shah, Chirag
Serrano Carmona, Raul Enrique
Abrégé
A system for regulating data downloads from an implantable pulse generator (IPG) includes an IPG configured to download data, receive signals, and provide electrical stimulation, and an external device configured to initiate a data download from the IPG and to direct the IPG to download the data for a first time period. The IPG and/or external device is configured to stop the data download after the first time period has expired and to wait a first time interval during which no data is downloaded and the IPG is available to receive signals from any external control devices. The IPG and/or external device is configured to initiate an additional data download from the IPG to the external device for a second time period after the first time interval has expired, and to repeat the steps until all data has been downloaded from the IPG to the external device.
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Gu, Jianwen
Esteller, Rosana
Abrégé
A system may be configured for treating a patient with epileptic seizures. The system may include a therapy delivery system configured to use a set of electrodes positioned adjacent to a spinal cord or dorsal column nuclei and a stimulation configuration to deliver neuromodulation energy to at least one target neural pathway in or near the spinal cord. The at least one target neural pathway includes the dorsal column nuclei or axons projecting to the dorsal column nuclei. The dorsal column nuclei and the axons are somatotopically organized and project to at least one of a cerebellum, a thalamus or a brainstem, which include somatotopically organized nuclei and project axons to different areas of a cortex. The at least one target neural pathway corresponds to at least one of the different areas of the cortex in which the epileptic seizures were located.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
28.
PARAMETERIZING TECHNIQUES FOR SUB-PERCEPTION AND PARESTHESIA THERAPY
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Haddock, Andrew James
Esteller, Rosana
Abrégé
A system for closed-loop control of sub-perception spinal cord stimulation therapy is provided. The system includes an implantable pulse generator (IPG) with an evoked compound action potential (ECAP) recording module and accelerometer. A regression model maps accelerometer data to optimal stimulation parameters for consistent nerve activation. This enables closed-loop therapy in the sub-perception domain where ECAP features are not visually detectable. A clinician programmer applies the model and sub-perception dose to therapy programs deployed to the IPG. The model can be customized to each patient by collecting ECAP and accelerometer data. The mapping reconciles ECAP-based control between perception and sub-perception domains by supplementing unavailable ECAP data with accelerometer data. This improves stimulation therapies for patients receiving sub-perception and multi-sensor paresthesia treatments.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
29.
LEAD INTRODUCERS AND SYSTEMS INCLUDING THE LEAD INTRODUCERS
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Nagaoka, Eric, Koji
Nageri, Ranjan, Krishna Mukhari
Abrégé
A lead introducer includes a combined needle/sheath having a splittable sheath configured to split along the length of the splittable sheath, a splittable hub coupled to the proximal end region of the splittable sheath and configured to split into a first portion and a second portion, a needle defining a channel extending along the length of the needle for delivery of a lead through the needle, where the needle is not bonded to the splittable hub and the splittable sheath, and a non-cylindrical locking fixture attached to, or part of a proximal end region of the needle, where the splittable hub includes a cavity having a shape complementary to the non-cylindrical locking fixture of the needle to hold the needle within the splittable hub and restrict rotation of the needle relative to the splittable hub. Another lead introducer includes a splittable hub and splittable needle attached to the splittable hub.
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Malekmohammadi, Mahsa
Moore, Lisa Denise
Abrégé
Methods and systems for pre-populating clinical effects maps for use in determining therapy parameters for a patient having a neuromodulation system. Neuromodulation planning may be aided by generating a map comparing electrode position and amplitudes used as a tool to test therapies on a patient and determine position and amplitude combinations associated with side effects and clinical benefits. The map may be pre-populated with borders indicating likely combinations for generating side effects and/or clinical benefits. The pre-populated map may be generated using the patient's anatomical data and data stored in a database.
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
31.
METHOD AND APPARATUS FOR PERSONALIZING NEUROSTIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Zhang, Tianhe
Thio, Bradon
Abrégé
A system for delivering neurostimulation to a patient may include a personalization circuit and a pattern optimization circuit. The personalization circuit may include an assessment input to receive patient-specific information resulting from a patient survey, a calibration input configured to receive calibration information resulting from a calibration, and personalization processing circuitry. The patient-specific information may include patient dimensions of the neurostimulation. The calibration information may include the patient's response to the neurostimulation. The personalization processing circuitry may be configured to determine a personalized objective function using the patient dimensions and to determine a personalized model having a model state personalized to the patient's response to the neurostimulation. The pattern optimization circuit may be configured to determine optimal pattern(s) of neurostimulation using the personalized objective function and the personalized model for programming a stimulation device to deliver the neurostimulation according to the optimal pattern(s) of neurostimulation.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
32.
METHOD AND APPARATUS FOR OPTIMIZING NEUROSTIMULATION FOR A PATIENT
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Thio, Brandon
Zhang, Tianhe
Abrégé
A system for delivering neurostimulation to a patient may include a pattern optimization circuit and a programming control circuit. The pattern optimization circuit may receive an objective function, a model, and one or more patterns of neurostimulation each including multiple stimulation parameters and may include optimization processing circuitry configured to determine an optimal pattern of neurostimulation using a simulation with the objective function, the model, and the one or more patterns of neurostimulation. The optimal pattern of neurostimulation including first stimulation parameter(s) each identified by the simulation to have a fixed value or value range with which a sensitivity to values of each of second stimulation parameter(s) on the objective function is identified by the simulation to be minimized. The programming control circuit may be configured to generate information for programming a stimulation device to control the delivery of the neurostimulation according to the optimal pattern of neurostimulation.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
33.
SIDE EFFECT PREDICTION AND EVALUATION FOR NEUROSTIMULATION TREATMENTS
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moore, Lisa Denise
Hoenes, Benjamin Ray
Juarez Paz, Leon Mauricio
Malekmohammadi, Mahsa
Abrégé
Systems and techniques are disclosed to identify and monitor side effects and treatment outcomes relating to neurostimulation programming. An example technique to identify a side effect relating to neurostimulation programming includes: obtaining neurostimulation programming parameters to be used in a neurostimulation device of a patient; obtaining source data that defines effects of neurostimulation treatment in an anatomical area of the patient; modeling use of the neurostimulation programming parameters in the anatomical area of the neurostimulation treatment, based on the source data, to determine a predicted side effect; and outputting information that identifies characteristics of the predicted side effect.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
34.
ANATOMICALLY INFORMED CLINICAL EFFECT MAPS IN APPLICATION OF DEEP BRAIN STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Malekmohammadi, Mahsa
Moore, Lisa Denise
Abrégé
Methods and systems for pre-populating clinical effects maps for use in determining therapy parameters for a patient having a neuromodulation system. Neuromodulation planning may be aided by generating a map comparing electrode position and amplitudes used as a tool to test therapies on a patient and determine position and amplitude combinations associated with side effects and clinical benefits. The map may be pre-populated with borders indicating likely combinations for generating side effects and/or clinical benefits. The pre-populated map may be generated using the patient's anatomical data and data stored in a database.
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Gu, Jianwen
Hershey, Bradley Lawrence
Zhu, Changfang
Abrégé
Methods and systems for modulating the neuroimmune response while monitoring biomarkers that may directly or indirectly correlate with neuroimmune function. A neuromodulation therapy may be delivered, and a biomarker level determined. Some biomarker levels are determined from bodily fluid collected from the patient, and are compared to a predetermined threshold level. A therapeutic stimulation is delivered to a patient using one or more electrode leads, and/or optical fibers.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 5/06 - Thérapie par radiations utilisant un rayonnement lumineux
36.
Current Generation Architecture for an Implantable Medical Device
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Weiss, Philip, L.
Marnfeldt, Goran, N.
Weerakoon, Pujitha
Abrégé
An implantable pulse generator (IPG) is disclosed having a plurality of electrode nodes, each electrode node configured to be coupled to an electrode to provide stimulation pulses to a patient’s tissue. The IPG includes a digital-to-analog converter configured to amplify a reference current to a first current specified by first control signals; a first resistance configured to receive the first current, wherein a voltage across the first resistance is held to a reference voltage at a first node; a plurality of branches each comprising a second resistance and configured to produce a branch current, wherein a voltage across each second resistance is held to the reference voltage at second nodes; and a switch matrix configurable to selectively couple any branch current to any of the electrode nodes via the second nodes.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
37.
LEAD INTRODUCERS AND SYSTEMS AND METHODS INCLUDING THE LEAD INTRODUCERS
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Nagaoka, Eric Koji
Nageri, Ranjan Krishna Mukhari
Abrégé
A lead introducer includes a combined needle/sheath having a splittable sheath configured to split along the length of the splittable sheath, a splittable hub coupled to the proximal end region of the splittable sheath and configured to split into a first portion and a second portion, a needle defining a channel extending along the length of the needle for delivery of a lead through the needle, where the needle is not bonded to the splittable hub and the splittable sheath, and a non-cylindrical locking fixture attached to, or part of, a proximal end region of the needle, where the splittable hub includes a cavity having a shape complementary to the non-cylindrical locking fixture of the needle to hold the needle within the splittable hub and restrict rotation of the needle relative to the splittable hub. Another lead introducer includes a splittable hub and splittable needle attached to the splittable hub.
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moffitt, Michael A.
Carbunaru, Rafael
Nageri, Ranjan Krishna Mukhari
Subramanian, Hari Hara
Abrégé
An electrical stimulation lead includes electrodes disposed on a cuff body and arranged into at least a first row, a second row, and a third row, where the second row is disposed between the first and third rows, and each electrode in the first row is electrically coupled to a corresponding electrode in the third row. In another electrical stimulation lead the electrodes are arranged so that the first and third rows each include multiple electrodes and the second row, between the first and third rows, includes at least one electrode with each electrode in the second row at least twice as long as each of the electrodes of the first and third rows. In another electrical stimulation lead the electrodes are arranged so that each electrode in the first and third rows is at least twice as long as each of the electrodes of the second row.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
39.
ELECTRICAL STIMULATION CUFF DEVICES AND SYSTEMS AND ELECTRODE ARRANGEMENTS THEREFOR
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Moffitt, Michael, A.
Carbunaru, Rafael
Nageri, Ranjan, Krishna Mukhari
Subramanian, Hari, Hara
Abrégé
An electrical stimulation lead includes electrodes disposed on a cuff body and arranged into at least a first row, a second row, and a third row, where the second row is disposed between the first and third rows, and each electrode in the first row is electrically coupled to a corresponding electrode in the third row. In another electrical stimulation lead the electrodes are arranged so that the first and third rows each include multiple electrodes and the second row, between the first and third rows, includes at least one electrode with each electrode in the second row at least twice as long as each of the electrodes of the first and third rows. In another electrical stimulation lead the electrodes are arranged so that each electrode in the first and third rows is at least twice as long as each of the electrodes of the second row.
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Nageri, Ranjan, Krishna Mukhari
Cisna, Austin
Gredzens, Alexander, Daniel
Ranpura, Himanshu
Abrégé
A connector assembly includes a coiled ring contact having a contact housing with a first part and a second part attached to the first part, wherein at least the first part includes a first radial sidewall and a first lateral sidewall extending laterally from the first radial sidewall, the first radial sidewall and the first lateral sidewall defining a pocket. The coiled ring contact also includes a coiled ring disposed within the contact housing, wherein the coiled ring contact is configured for disposal of the coiled ring within the pocket defined by the first part of the contact housing and prior to attachment of the second part to the first part.
A61N 1/375 - Aménagements structurels, p. ex. boîtiers
H01R 13/187 - Broches, lames ou alvéoles ayant un ressort indépendant pour produire ou améliorer la pression de contact le ressort étant dans l'alvéole
H01R 24/58 - Contacts espacés le long de l'axe longitudinal d’engagement
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Gu, Jianwen
Abrégé
Methods and systems for addressing issues related to synchrony in neural tissue signals. A spectrum of neural signals in a patient may be measured while the patient is asymptomatic, and compared to signals during a symptomatic episode to determine whether neural signals should be enhanced or disrupted. Depending on the change to neural signals, either enhancing or disrupting neural therapy is generated and confirmed or adjusted.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Gu, Jianwen
Abrégé
Methods and systems for addressing issues related to synchrony in neural tissue signals. A spectrum of neural signals in a patient may be measured while the patient is asymptomatic, and compared to signals during a symptomatic episode to determine whether neural signals should be enhanced or disrupted. Depending on the change to neural signals, either enhancing or disrupting neural therapy is generated and confirmed or adjusted.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
43.
COILED RING CONTACTS FOR ELECTRICAL STIMULATION SYSTEMS AND METHODS OF MAKING AND USING SAME
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Nageri, Ranjan Krishna Mukhari
Cisna, Austin
Gredzens, Alexander Daniel
Ranpura, Himanshu
Abrégé
A connector assembly includes a coiled ring contact having a contact housing with a first part and a second part attached to the first part, wherein at least the first part includes a first radial sidewall and a first lateral sidewall extending laterally from the first radial sidewall, the first radial sidewall and the first lateral sidewall defining a pocket. The coiled ring contact also includes a coiled ring disposed within the contact housing, wherein the coiled ring contact is configured for disposal of the coiled ring within the pocket defined by the first part of the contact housing and prior to attachment of the second part to the first part.
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Zhu, Changfang
Abrégé
An example of a system may include an electrode arrangement and a neuromodulation device configured to use electrodes in the electrode arrangement to generate a neuromodulation field. The neuromodulation device may include a neuromodulation generator, a neuromodulation control circuit and a storage. The storage may include a stochastically-modulated neuromodulation parameter set and the stochastically-modulated neuromodulation parameter set may include at least one stochastically-modulated parameter. The controller may be configured to control the neuromodulation generator using the stochastically-modulation parameter set to generate the neuromodulation field.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
46.
SYSTEMS AND METHODS FOR SPATIALLY SELECTIVE SPINAL CORD STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Zhang, Tianhe
Doan, Que T.
Abrégé
A system may include electrodes on at least one lead configured to be operationally positioned for use in modulating a volume of neural tissue, a neural modulation generator configured to deliver energy using at least some electrodes to modulate the volume of neural tissue, a programming system configured to program the programmed modulation parameter set, including determine electrode fractionalizations for the electrodes based on a target multipole. The programmed parameter set may include the determined electrode fractionalizations. The target multipole may be used to determine electrode fractionalizations having at least three target poles that directionally and progressively stack fractionalizations of target poles to provide a linear electric field over the volume of tissue. The neural modulation generator may be configured to use the programmed modulation parameter set to provide the linear electric field over the volume of tissue.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Abrégé
A system may include a stimulus circuit configured to provide electrostimulation to a neural target of a patient via electrodes on a lead, a sensing circuit configured to sense evoked, response (ER) signals produced by the electrostimulation, a user interface, and a controller operably connected to the stimulus circuit, the sensing circuit, and the user interface. The controller is configured to initiate delivery of the electrostimulation to the electrodes, identify ER signal features of the sensed ER signals, compute a longitudinal distribution of the ER signal features for a longitudinal direction of the lead, compute a rotational distribution that is a is a periodic distribution of the ER signal features for an angular direction of the lead, and display peak regions of the longitudinal distribution and the rotational distribution as a hotspot view of the sensed ER signals on the user interface.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moffitt, Michael A.
Brill, Natalie A.
Gu, Jianwen
Hincapie Ordonez, Juan Gabriel
Zhu, Changfang
Bokil, Hemant
Carcieri, Stephen
Abrégé
An example of a system may include a processor and a memory device comprising instructions, which when executed by the processor, cause the processor to: access a patient metric of a subject; use the patient metric as an input to a machine learning algorithm, the machine learning algorithm to search a plurality of neuromodulation parameter sets and to identify a candidate neuromodulation parameter set of the plurality of neuromodulation parameter sets, the candidate neuromodulation parameter set designed to produce a non-regular waveform that varies over a time domain and a space domain; and program a neuromodulator using the candidate neuromodulation parameter set to stimulate the subject.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/02 - ÉlectrothérapieCircuits à cet effet Parties constitutives
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
Boston Scientific Neuromodulaton Corporation (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Abrégé
A system may include a stimulus circuit configured to provide electrostimulation to a neural target of a patient via electrodes on a lead, a sensing circuit configured to sense evoked response (ER) signals produced by the electrostimulation, a user interface, and a controller operably connected to the stimulus circuit, the sensing circuit, and the user interface. The controller is configured to initiate delivery of the electrostimulation to the electrodes, identify ER signal features of the sensed ER signals, compute a longitudinal distribution of the ER signal features for a longitudinal direction of the lead, compute a rotational distribution that is a is a periodic distribution of the ER signal features for an angular direction of the lead, and display peak regions of the longitudinal distribution and the rotational distribution as a hotspot view of the sensed ER signals on the user interface.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
50.
METHODS AND SYSTEMS FOR TARGET LOCALIZATION AND DBS THERAPY
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Esteller, Rosana
Malekmohammadi, Mahsa
Haddock, Andrew
Zhang, Tianhe
Abrégé
Methods and systems are described for detecting if a stimulation lead implanted in a patient's brain has moved. Lead movement occurring between a first time and a second time may be determined by comparing features extracted from evoked potentials recorded at the two times. The disclosed methods and systems are particularly useful for determining if a stimulation lead has moved between the time it was implanted in the patient's brain and the time that stimulation parameters are being optimized. Lead movement during implantation, during parameter optimization, and during or between other lead optimization processes may be determined as well.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
51.
METHODS AND SYSTEMS FOR CONTROL AND MODIFICATION OF STIMULATION
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
52.
INTEGRATION OF FIBER TRACTS INTO DEEP BRAIN STIMULATION TARGETING
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Mustakos, Richard
Malekmohammadi, Mahsa
Carcieri, Stephen
Abrégé
Systems and methods for configuring neurostimulation systems to identify optimal therapies for use in a patient. Positional data for a lead implanted in the patient and anatomical data are obtained. Non-linear response structures are identified in the patient, and therapy metrics are generated using non-linear functions of the quantity of volume segments in the non-linear response structures that would be activated by a given therapy configuration including a combination of current fractionalization and current amplitude.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
G16H 40/00 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
53.
METHOD FOR ARBITRATION BETWEEN PULSES IN A NEUROSTIMULATION DEVICE
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Weiss, Philip Leonard
Abrégé
Methods and devices for controlling arbitration in an implantable medical device capable of issuing therapy stimulus for a plurality of therapy programs. The system defines a therapy program at multiple levels including pulse programs, aggregate instructions, and therapy programs. Holdoff and/or arbitration settings are available at several levels of the therapy program definition, allowing increased flexibility and control.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
54.
LINKING PULSE PATTERNS IN A NEUROSTIMULATION DEVICE
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Weiss, Philip Leonard
Abrégé
An implantable neurostimulation device is configured with a current delivery architecture having at least two digital to analog converters (DACs), and a therapy definition circuit using therapy configurations is provided that allows two therapy configurations to be linked together. When two therapy configurations are linked, each therapy configuration uses a different one of the DACs to deliver therapy in overlapping or simultaneous fashion, using identical or different electrodes.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
55.
INTEGRATION OF FIBER TRACTS INTO DEEP BRAIN STIMULATION TARGETING
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Mustakos, Richard
Malekmohammadi, Mahsa
Carcieri, Stephen
Abrégé
Systems and methods for configuring neurostimulation systems to identify optimal therapies for use in a patient. Positional data for a lead implanted in the patient and anatomical data are obtained. Non-linear response structures are identified in the patient, and therapy metrics are generated using non-linear functions of the quantity of volume segments in the non-linear response structures that would be activated by a given therapy configuration including a combination of current fractionalization and current amplitude.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
56.
SYSTEMS AND METHODS FOR TARGETING AND DOSING SPINAL CORD STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Zhang, Tianhe
Esteller, Rosana
Doan, Que T.
Abrégé
Methods and systems for performing spinal cord stimulation in the cervical spine while sensing for an evoked response, such as an evoked synaptic action potential (ESAP) at a different location from the location of stimulation. A first lead may be positioned in the cervical spine for issuing therapy pulses, and sensing is performed at a thoracic or lumbar location, or a caudal cervical location relative to the location of stimulation. First and second leads may be used in a single system, or two separate systems, one for stimulation and another for sensing, may be used.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
57.
PHOTOBIOMODULATION OF BASAL FOREBRAIN TO IMPROVE COGNITION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Gu, Jianwen
Zhu, Changfang
Abrégé
A multi-modal method of stimulation to the basal forebrain to enhance the neuroprotective effects of deep brain stimulation and photobiomodulation. Stimulation is generated by a lead that incorporates optical devices and electrodes placed either intracranially or intranasally. By using this combination therapy, both electrical and optical stimulation, and its therapeutic benefits, can be incorporated within one treatment regimen.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 5/06 - Thérapie par radiations utilisant un rayonnement lumineux
58.
INTEGRATION OF RELATED PROBABILITY SHELLS INTO DEEP BRAIN STIMULATION TARGETING
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Mustakos, Richard
Malekmohammadi, Mahsa
Smith, Iii, Stephen Randolph
Abrégé
Methods and systems for analyzing and selecting therapy configurations for use in stimulating neural tissue. Probability shells relating to a likelihood that electrical stimulation issued to a given volume of neural tissue will cause a therapeutic outcome are integrated in a system for analyzing anatomical and other data, including lead position relative to neural anatomy. Metrics for analyzing therapy configurations can then be calculated, and the process of identifying likely beneficial therapy configurations is enhanced.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 30/20 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le maniement d’images médicales, p. ex. DICOM, HL7 ou PACS
59.
METHOD AND APPARATUS FOR SELECTING NEUROMODULATION PARAMETERS USING ELECTROSPINOGRAM
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Esteller, Rosana
Abrégé
An example of a system for delivering neurostimulation energy may include a stimulation control circuit to control the delivery of the neurostimulation energy according to each of stimulation test patterns. The stimulation control circuit may include a sensing input configured to receive an electrospinogram (ESG) signal recording electrical activity from the spinal cord, a measurement circuit configured to determine one or more response parameters for each test pattern using the received ESG signal, and a selection circuit configured to select a neurostimulation therapy pattern from the stimulation test patterns based on the response parameter(s) and one or more selection criteria. The electrical activity includes responses to the delivered neurostimulation energy, and the response parameter(s) are each indicative of one or more characteristics of the responses. The selection may include selecting a type of stimulation waveform from multiple types of stimulation waveform in the stimulation test patterns.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Zhang, Tianhe
Doan, Que
Abrégé
A fitting algorithm for a spinal cord stimulator is disclosed, which is preferably implemented in a clinician programmer having a graphical user interface. In one example, coupling parameters indicative of coupling to neural structures are determined for each electrode in an implanted electrode array. The user interface associates different pole configurations with different anatomical targets and with different measurement techniques (subjective or objective) to gauge the effectiveness of the pole configuration at different positions in the electrode array. The pole configuration, perhaps as modified by the coupling parameters, is then steered in the array, and effectiveness is measured along with a paresthesia threshold at each position. Using at least this data, the fitting algorithm can determine one or more candidate positions in the electrode array at which a therapeutic stimulation program can be centered.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
61.
METHOD FOR ARBITRATION BETWEEN PULSES IN A NEUROSTIMULATION DEVICE
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Weiss, Philip Leonard
Abrégé
Methods and devices for controlling arbitration in an implantable medical device capable of issuing therapy stimulus for a plurality of therapy programs. The system defines a therapy program at multiple levels including pulse programs, aggregate instructions, and therapy programs. Holdoff and/or arbitration settings are available at several levels of the therapy program definition, allowing increased flexibility and control.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
62.
LINKING PULSE PATTERNS IN A NEUROSTIMULATION DEVICE
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Weiss, Philip, Leonard
Abrégé
An implantable neurostimulation device is configured with a current delivery architecture having at least two digital to analog converters (DACs), and a therapy definition circuit using therapy configurations is provided that allows two therapy configurations to be linked together. When two therapy configurations are linked, each therapy configuration uses a different one of the DACs to deliver therapy in overlapping or simultaneous fashion, using identical or different electrodes.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/02 - ÉlectrothérapieCircuits à cet effet Parties constitutives
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
63.
SYSTEMS AND METHODS FOR TARGETING AND DOSING SPINAL CORD STIMULATION
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Zhang, Tianhe
Esteller, Rosana
Doan, Que T.
Abrégé
Methods and systems for performing spinal cord stimulation in the cervical spine while sensing for an evoked response, such as an evoked synaptic action potential (ESAP) at a different location from the location of stimulation. A first lead may be positioned in the cervical spine for issuing therapy pulses, and sensing is performed at a thoracic or lumbar location, or a caudal cervical location relative to the location of stimulation. First and second leads may be used in a single system, or two separate systems, one for stimulation and another for sensing, may be used.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
64.
PHOTOBIOMODULATION OF BASAL FOREBRAIN TO IMPROVE COGNITION
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Gu, Jianwen
Zhu, Changfang
Abrégé
A multi-modal method of stimulation to the basal forebrain to enhance the neuroprotective effects of deep brain stimulation and photobiomodulation. Stimulation is generated by a lead that incorporates optical devices and electrodes placed either intracranially or intranasally. By using this combination therapy, both electrical and optical stimulation, and its therapeutic benefits, can be incorporated within one treatment regimen.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/365 - Stimulateurs cardiaques commandés par un paramètre physiologique, p. ex. par le potentiel cardiaque
A61N 5/06 - Thérapie par radiations utilisant un rayonnement lumineux
65.
INTEGRATION OF RELATED PROBABILITY SHELLS INTO DEEP BRAIN STIMULATION TARGETING
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Mustakos, Richard
Malekmohammadi, Mahsa
Smith Iii, Stephen Randolph
Abrégé
Methods and systems for analyzing and selecting therapy configurations for use in stimulating neural tissue. Probability shells relating to a likelihood that electrical stimulation issued to a given volume of neural tissue will cause a therapeutic outcome are integrated in a system for analyzing anatomical and other data, including lead position relative to neural anatomy. Metrics for analyzing therapy configurations can then be calculated, and the process of identifying likely beneficial therapy configurations is enhanced.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
G16H 30/00 - TIC spécialement adaptées au maniement ou au traitement d’images médicales
G16H 40/00 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux
G16H 50/00 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Malekmohammadi, Mahsa
Bokil, Hemant
Steinke, G. Karl
Abrégé
An example method of operating a neuromodulation device to modify or achieve a desired arousal state in a patient may include determining the patient's desired arousal state, detecting one or more signals that are related to the desired arousal state, where the one or more signals are sensed from the patient or provided by an external source. The method also includes determining, via a controller circuit, a therapy parameter setting for the neuromodulation device based on the one or more signals, and generating, via the controller circuit, a control signal in the neuromodulation device to initiate or adjust an arousal state therapy program in accordance with the therapy parameter setting.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
68.
Automated Selection of Electrodes and Stimulation Parameters in a Deep Brain Stimulation System
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moore, Lisa
Soni, Bhaskar
Fischell, Rachel
Shah, Chirag
Abrégé
A programming algorithm is disclosed to efficiently select stimulation parameters for a patient having a Deep Brain Stimulation (DBS) implant. The algorithm preferably first determines an optimal longitudinal position (Lopt) and amplitude (Iopt1) for stimulation along the lead. This occurs by the algorithm efficiently suggested various values for L and I at which stimulation can be tried on the patient and scored. Once Lopt is determined, the algorithm can also determine an optimal rotational angle (θopt) and amplitude (Iopt2) for stimulation around the lead at the optimized longitudinal position Lopt. This also occurs by the algorithm efficiently suggesting various values for θ and I at which stimulation can be tried on the patient and scored. Despite suggesting next L,I or θ,I values to test, the algorithm allows flexibility to allow a user to test any desired stimulation parameters beyond those suggested.
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
69.
METHODS AND SYSTEMS FOR CONTROL AND MODIFICATION OF STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moore, Lisa Denise
Yoo, Peter J.
Abrégé
Electrical stimulation systems and methods for operation and management of the electrical stimulation system are described. One method for operation of an electrical stimulation system includes receiving a request to modify stimulation; displaying a graph for at least one adjustable stimulation parameter; indicating on the graph a current setting of each of the at least one adjustable stimulation parameter and a range around the current setting of at least one of the at least one adjustable stimulation parameter which represents at least one of a minor change in the stimulation based on a predefined minor change criteria or a moderate change in the stimulation based on a predefined moderate change criteria; receiving a selection of a new setting for at least one of the at least one adjustable stimulation parameter; and modifying the stimulation according to the selection.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Gu, Jianwen
Esteller, Rosana
Abrégé
A system may be configured for treating a condition and may include at least one therapy delivery system, at least one event detector and a controller. The therapy delivery system(s) may be configured to deliver at least two therapies to at least two therapy targets including deliver a. first therapy to a first therapy target and deliver a second therapy to a. second therapy target. The event detector(s) may be configured to detect at least one predefined event. The controller may be configured to coordinate the therapies based on the detected predefined event(s) using at least one defined event-therapy relationship.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
G16H 40/00 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Gu, Jianwen
Esteller, Rosana
Abrégé
A system may be configured for treating a condition and may include at least one therapy delivery system, at least one event detector and a controller. The therapy delivery system(s) may be configured to deliver at least two therapies to at least two therapy targets including deliver a first therapy to a first therapy target and deliver a second therapy to a second therapy target. The event detector(s) may be configured to detect at least one predefined event. The controller may be configured to coordinate the therapies based on the detected predefined event(s) using at least one defined event-therapy relationship.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/02 - ÉlectrothérapieCircuits à cet effet Parties constitutives
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Malekmohammadi, Mahsa
Bokil, Hemant
Steinke, G. Karl
Abrégé
An example method of operating a neuromodulation device to modify or achieve a desired arousal state in a patient may include determining the patient's desired arousal state, detecting one or more signals that are related to the desired arousal state, where the one or more signals are sensed from the patient or provided by an external source. The method also includes determining, via a controller circuit, a therapy parameter setting for the neuromodulation device based on the one or more signals, and generating, via the controller circuit, a control signal in the neuromodulation device to initiate or adjust an arousal state therapy program in accordance with the therapy parameter setting.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
73.
SYSTEMS AND METHODS FOR NEUROMODULATION BASED ON SELECTIVE EVOKED RESPONSES
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Abrégé
Systems and methods for selective sensing of evoked responses (ERs) and using the ERs to guide neuromodulation are disclosed. An exemplary system comprises at least one multi-electrode lead, an electrostimulator to provide electrostimulation to a neural target, a sensing circuit to sense ERs to electrostimulation, and a controller circuit. In response to electrostimulation delivered to the neural target in accordance with a stimulation setting via a stimulating electrode, the controller circuit can collect ERs from each of a group of sensing electrodes selected from and less than an entirety of the electrodes on the lead. The selected electrodes can be distinct from the stimulating electrode, or within a specific proximity to the stimulating electrode. Based on a comparison of the sensed ERs to acceptance criteria, the controller circuit can provide a recommendation to reposition the lead or to adjust the stimulation setting.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/375 - Aménagements structurels, p. ex. boîtiers
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Hoenes, Benjamin Ray
Abrégé
Systems and methods for modelling a spatial distribution of evoked responses (ERs) to electrostimulation and using the model to guide neuromodulation are disclosed. An exemplary system comprises at least one multi-electrode lead, an electrostimulator to provide electrostimulation to a neural target, a sensing circuit to sense ERs to electrostimulation, and a controller circuit. In response to electrostimulation delivered to the neural target in accordance with a stimulation setting via a stimulating electrode, the controller circuit can collect ERs from each of a group of sensing electrodes positioned at respective sensing locations and selected from the electrodes on the at least one lead, generate a model representing a spatial distribution of ER features of the sensed ERs, and based on a comparison of the model to acceptance criteria, provide a recommendation to reposition the lead or to adjust the stimulation setting.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/375 - Aménagements structurels, p. ex. boîtiers
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
75.
System and Method for Ensuring a Consistent Connection of Electrodes to a Replacement Implantable Medical Device
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Shah, Chirag
Steinke, G. Karl
Abrégé
Implantable medical devices (IMD) such as those used in Deep Brain Stimulation application are commonly replaced when the device's useful life expires. At the time of replacement, the electrodes that were connected to the initial IMD are typically reused with the replacement IMD. It is desirable for the replacement IMD to utilize the stimulation parameters that were being utilized to provide stimulation in the initial IMD, but it is important that the electrodes be connected to the replacement IMD in a similar manner as they were connected to the initial IMD if stimulation parameters are reused. A connected electrode profile that includes measurements of electrical parameters associated with the electrodes can be generated in the initial IMD and the replacement IMD, and the profiles can be compared to determine whether the electrodes are connected in a similar manner in the replacement IMD as they were in the initial IMD.
A61N 1/375 - Aménagements structurels, p. ex. boîtiers
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/08 - Aménagements ou circuits de surveillance, de protection, de commande ou d'indication
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
76.
NEUROMODULATION THERAPY BASED ON SELECTIVE EVOKED RESPONSES
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Abrégé
Systems and methods for selective sensing of evoked responses (ERs) and using the ERs to guide neuromodulation are disclosed. -An exemplary system comprises at least one multi -electrode lead, an electrostimulator to provide electrostimulation to a. neural target, a. sensing circuit to sense ERs to electrostimulation, and a controller circuit. In response to electrostimulation delivered to the neural target in accordance with a stimulation setting via a. stimulating electrode, the controller circuit can collect ERs from each of a group of sensing electrodes selected from and less than an entirety of the electrodes on the lead. The selected electrodes can be distinct from the stimulating electrode, or within a specific proximity to the stimulating electrode. Based on a comparison of the sensed ERs to acceptance criteria, the controller circuit can provide a recommendation to reposition the lead or to adjust the stimulation setting.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61B 5/388 - Études de la conduction nerveuse, p. ex. détection du potentiel d’action d’un nerf périphérique
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
77.
NEUROMODULATION THERAPY BASED ON SELECTIVE EVOKED RESPONSES
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Abrégé
Systems and methods for selective sensing of evoked responses (ERs) and using the ERs to guide neuromodulation are disclosed. -An exemplary system comprises at least one multi -electrode lead, an electrostimulator to provide electrostimulation to a. neural target, a. sensing circuit to sense ERs to electrostimulation, and a controller circuit. In response to electrostimulation delivered to the neural target in accordance with a stimulation setting via a. stimulating electrode, the controller circuit can collect ERs from each of a group of sensing electrodes selected from and less than an entirety of the electrodes on the lead. The selected electrodes can be distinct from the stimulating electrode, or within a specific proximity to the stimulating electrode. The controller circuit can use a comparison of the sensed ERs to acceptance criterion to aid in lead placement and stimulation programming.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
78.
SYSTEMS AND METHODS FOR NEUROMODULATION BASED ON SELECTIVE EVOKED RESPONSES
BOSTON Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Abrégé
Systems and methods for selective sensing of evoked responses (ERs) and using the ERs to guide neuromodulation are disclosed. An exemplary system comprises at least one multi-electrode lead, an electrostimulator to provide electrostimulation to a neural target, a sensing circuit to sense ERs to electrostimulation, and a controller circuit. In response to electrostimulation delivered to the neural target in accordance with a stimulation setting via a stimulating electrode, the controller circuit can collect ERs from each of a group of sensing electrodes selected from and less than an entirety of the electrodes on the lead. The selected electrodes can be distinct from the stimulating electrode, or within a specific proximity to the stimulating electrode. The controller circuit can use a comparison of the sensed ERs to acceptance criterion to aid in lead placement and stimulation programming.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/375 - Aménagements structurels, p. ex. boîtiers
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Hoenes, Benjamin Ray
Abrégé
Systems and methods for modelling a spatial distribution of evoked responses (ERs) to electrostimulation and using the model to guide neuromodulation are disclosed. An exemplary system comprises at least one multi-electrode lead, an electrostimulator to provide electrostimulation to a neural target, a. sensing circuit to sense ERs to electrostimulation, and a. controller circuit. In response to electrostimulation delivered to the neural target in accordance with a stimulation setting via a stimulating electrode, the controller circuit can collect ERs from each of a group of sensing electrodes positioned at respective sensing locations and selected from the electrodes on the at least one lead, generate a model representing a spatial distribution of ER features of the sensed ERs, and based on a comparison of the model to acceptance criteria, provide a recommendation to reposition the lead or to adjust the stimulation setting.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
80.
External Charger for an Implantable Medical Device For Adjusting Charging Power Based on Determined Position Using at Least One Sense Coil
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Aghassian, Daniel
Stouffer, Thomas W.
Larcom, Jonathan
Gupta, Gaurav
Abrégé
A charging system for an Implantable Medical Device (IMD) is disclosed having a charging coil and one or more sense coils preferably housed in a charging coil assembly coupled to an electronics module by a cable. The charging coil is preferably a wire winding, while the sense coils are preferably formed in one or more traces of a circuit board. One or more voltages induced on the one or more sense coils can be used to determine one or more parameters (magnitude, phase angle, resonant frequency) indicative of the position between the charging coil and the IMD, which position may include the radial offset and possibly also the depth of the charging coil relative to the IMD. Knowing the position, the power of the magnetic field produced by the charging coil can be adjusted to compensate for the position.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
H02J 7/00 - Circuits pour la charge ou la dépolarisation des batteries ou pour alimenter des charges par des batteries
H02J 50/00 - Circuits ou systèmes pour l'alimentation ou la distribution sans fil d'énergie électrique
H02J 50/12 - Circuits ou systèmes pour l'alimentation ou la distribution sans fil d'énergie électrique utilisant un couplage inductif du type couplage à résonance
H02J 50/80 - Circuits ou systèmes pour l'alimentation ou la distribution sans fil d'énergie électrique mettant en œuvre l’échange de données, concernant l’alimentation ou la distribution d’énergie électrique, entre les dispositifs de transmission et les dispositifs de réception
H02J 50/90 - Circuits ou systèmes pour l'alimentation ou la distribution sans fil d'énergie électrique mettant en œuvre la détection ou l'optimisation de la position, p. ex. de l'alignement
81.
INFERRING LEAD PLACEMENT BASED ON SENSED BIOMARKERS
Boston Scientific Neuromodulation Coporation (USA)
Inventeur(s)
Witwer, Max
Zhang, Tianhe
Abrégé
A system may include an electrode arrangement and a neurostimulator. The electrode arrangement may have a length generally in a rostral-caudal direction and a width generally in a mediolateral direction. The electrode arrangement may include a first set and a second set of electrodes spaced across the width. The neurostimulator may be configured to stimulate a sequence of locations of the patient using subsets of the first set of electrodes, and for each stimulated location in the stimulated sequence of locations identify corresponding response measures for each one of the second set of electrodes. The physiological midline may be inferred or identified from these measurements, which may be used to guide lead placement and/or programming.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/02 - ÉlectrothérapieCircuits à cet effet Parties constitutives
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
82.
Pairing of External Communication Devices With an Implantable Medical Device via a Patient Remote Controller
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Shah, Chirag
Yoo, Peter
Abrégé
Techniques for pairing an external device such as a clinician programmer (CP) to an implantable medical device (IMD) are disclosed, which involve use of a remote controller (RC) paired to the IMD. The RC is placed into a CP pairing mode, which acts differently depending on the type of IMD paired to the RC. If the IMD is RF based, the CP pairing mode places the IMD in a pairing mode, thus allowing the CP to connect directly with the IMD via a RF telemetry protocol. If the IMD is magnetic-induction based, the CP pairing mode causes the RC to advertise its presence to the CP, allowing the CP to connect to the RC via the RF telemetry protocol. Because the RC is also paired with the IMD via a magnetic induction telemetry protocol, the RC acts as a passthrough device to allow communications between the CP and the IMD.
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Witwer, Max
Zhang, Tianhe
Abrégé
A system may include an electrode arrangement and a neurostimulator. The electrode arrangement may have a length generally in a rostral -caudal direction and a width generally in a mediolateral direction. The electrode arrangement may include a first set and a second set of electrodes spaced across the width. The neurostimulator may be configured to stimulate a sequence of locations of the patient using subsets of the first set of electrodes, and for each stimulated location in the stimulated sequence of locations identify corresponding response measures for each one of the second set of electrodes. The physiological midline may be inferred or identified from these measurements, which may be used to guide lead placement and/or programming.
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
84.
SYSTEMS AND METHODS WITH ACTIVATING RECHARGE STIMULATION
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Thio, Brandon
Zhang, Tianhe
Abrégé
A neurostimulation system may include at least one electrode contact and a neurostimulator configured to use the at least one electrode contact to deliver a stimulation therapy to a patient using an electrical waveform that includes first- phases of a. first polarity and second phases of a second polarity opposite the first polarity. The neurostimulator may configured to deliver the stimulation therapy by therapeutically stimulating neural tissue using the both the first phases and the second phases of the electrical waveform. The second phases remove built up charge from the at least one electrode contact caused by the first phases, and the first phases remove built up charge from the at least one electrode contact caused by the second phases. Benefits include reducing energy consumption using the recharge pulse to activate a population of neural elements for reducing energy consumption.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
85.
SYSTEMS AND METHODS WITH ACTIVATING RECHARGE STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Thio, Brandon
Zhang, Tianhe
Abrégé
A neurostimulation system may include at least one electrode contact and a neurostimulator configured to use the at least one electrode contact to deliver a stimulation therapy to a patient using an electrical waveform that includes first phases of a first polarity and second phases of a second polarity opposite the first polarity. The neurostimulator may configured to deliver the stimulation therapy by therapeutically stimulating neural tissue using the both the first phases and the second phases of the electrical waveform. The second phases remove built up charge from the at least one electrode contact caused by the first phases, and the first phases remove built up charge from the at least one electrode contact caused by the second phases. Benefits include reducing energy consumption using the recharge pulse to activate a population of neural elements for reducing energy consumption.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
86.
SYSTEMS AND METHODS FOR DORSAL NERVE ROOT STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Block, Jessica
Esteller, Rosana
Abrégé
A system may include at least one lead, a stimulation waveform generator, and a controller. The controller may be programmed to implement a process to suggest at least one electrode to be used to stimulate the nerve root. A therapeutic window may be determined for each electrode. For each electrode determining the therapeutic window may include applying stimulation, determining a first stimulation threshold for the applied stimulation to cause a first physiological effect, determining a second stimulation threshold for the applied stimulation to cause a second physiological effect, and determining a difference between the first stimulation threshold and the second stimulation threshold, wherein the difference is the therapeutic window. The process may further include determining at electrode(s) with a minimum value for the therapeutic window, and suggesting the electrode(s) to be used to stimulate the nerve root based on the determined electrode(s) with the minimum value.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
87.
SYSTEMS AND METHODS FOR DETECTINC; SIGNAL EXTREMUM
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Weiss, Philip Leonard
Abrégé
A system may include data acquisition circuitry, local extremum detection circuitry, difference monitoring circuitry, comparator circuitry and extremum data recorder circuitty. The data acquisition circuitry may be configured to access a series of data, samples from a sensor signal. The local extremum detection circuitry may be configured to find a local extremum in the series of data samples. The difference monitoring circuitry may be configured to determine a difference between the local extremum and the series of data samples subsequent to and receding from the local extremum toward the first- direction. The comparator circuitry may be configured to compare the difference to a predefined threshold. The extremum data recorder circuitry may be configured to write extremum data into storage when the difference exceeds the predefined threshold.
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Weiss, Philip Leonard
Abrégé
A system may include data acquisition circuitry, local extremum detection circuitry, difference monitoring circuitry, comparator circuitry and extremum data recorder circuitry. The data acquisition circuitry may be configured to access a series of data samples from a sensor signal. The local extremum detection circuitry may be configured to find a local extremum in the series of data samples. The difference monitoring circuitry may be configured to determine a difference between the local extremum and the series of data samples subsequent to and receding from the local extremum toward the first direction. The comparator circuitry may be configured to compare the difference to a predefined threshold. The extremum data recorder circuitry may be configured to write extremum data into storage when the difference exceeds the predefined threshold.
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
89.
Passive Charge Recovery Circuitry for an Implantable Medical Device
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Feldman, Emanuel
Marnfeldt, Goran N.
Parramon, Jordi
Abrégé
Recovery circuitry for passively recovering charge from capacitances at electrodes in an Implantable Pulse Generator (IPG) is disclosed. The passive recovery circuitry includes passive recovery switches intervening between each electrode node and a common reference voltage, and each switch is in series with a variable resistance that may be selected based on differing use models of the IPG. The passive recovery switches may also be controlled in different modes. For example, in a first mode, the only recovery switches closed after a stimulation pulse are those associated with electrodes used to provide stimulation. In a second mode, all recovery switches are closed after a stimulation pulse, regardless of the electrodes used to provide stimulation. In a third mode, all recovery switches are closed continuously, which can provide protection when the IPG is in certain environments (e.g., MRI), and which can also be used during stimulation therapy itself.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/02 - ÉlectrothérapieCircuits à cet effet Parties constitutives
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Abrégé
This document discusses a. computer-implemented method of operating a neurostimulation device to deliver electrical neurostimulation when connected to an implantable stimulation lead. The method includes delivering neurostimulation to a subject using the neurostimulation device; recording electrical signals sensed using the implantable stimulation lead; extracting one or more features from the recorded electrical signals; detecting clustering of the one or more extracted, features of the recorded electrical signals; and identifying, by the neurostimulation device, an evoked response signal of interest from among the recorded electrical signals using the detected clustering of the one or more extracted features of the recorded electrical signals.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/395 - Détails de la stimulation, p. ex. stimulation d’un nerf pour provoquer une réponse EMG
A61B 5/388 - Études de la conduction nerveuse, p. ex. détection du potentiel d’action d’un nerf périphérique
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Steinke, G. Karl
Fraczek, Tomasz Mark
Abrégé
This document discusses a computer-implemented method of operating a neurostimulation device to deliver electrical neurostimulation when connected to an implantable stimulation lead. The method includes delivering neurostimulation to a subject using the neurostimulation device; recording electrical signals sensed using the implantable stimulation lead; extracting one or more features from the recorded electrical signals; detecting clustering of the one or more extracted features of the recorded electrical signals; and identifying, by the neurostimulation device, an evoked response signal of interest from among the recorded electrical signals using the detected clustering of the one or more extracted features of the recorded electrical signals.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/375 - Aménagements structurels, p. ex. boîtiers
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Moore, Lisa Denise
Hoenes, Benjamin Ray
Abrégé
A system may include a stimulator configured to deliver a DBS therapy according to a first therapy program, and a processing system. The processing system may be configured for use to receive a logged event indicative of an acute reduction in therapy, automatically identify a second therapy program for the DBS therapy to address the acute reduction in therapy, deliver the DBS therapy according to the second therapy program, prompt the user to report whether the user likes or dislikes the DBS therapy delivered according to the second therapy program, and control the DBS therapy based on the report by choosing a third therapy program, reverting to the first therapy program, or continuing to deliver the DBS therapy according to the second therapy program.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/375 - Aménagements structurels, p. ex. boîtiers
G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
93.
SYSTEMS AND METHODS FOR SELECTING ELECTRODES AND PROVIDING STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Bokil, Hemant
Abrégé
Method and systems are described for identifying electrodes for stimulation of a patient using a stimulation system. The stimulation system includes at least one stimulation lead implanted in a patient and having electrodes disposed thereon. The method includes obtaining a plurality of bioelectrical signals, wherein each of the bioelectrical signals is obtained using a different one, or a different combination, of the electrodes; analyzing a dataset including the bioelectrical signals to identify at least one fundamental component of the dataset, each of the at least one fundamental component identifying a contribution of one or more of the electrodes to the fundamental component; and using at least one of the at least one fundamental component to identify one or more of the electrodes for stimulation according to the contribution of each of the one or more of the electrodes to the at least one of the at least one fundamental component.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
94.
SYSTEMS AND METHODS FOR SELECTABLE LATERAL SPINAL CORD STIMULATION
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Block, Jessica
Esteller, Rosana
Carbunaru, Rafael
Abrégé
Systems and methods for selectable lateral spinal cord stimulation are discussed. An exemplary neuromodulation system includes a programming device and an electrostimulator. The programming device can receive information about placement of at least one lead in a vicinity of a lateral portion of a spinal cord, identify one or more lateral spinal neural targets based on the information about placement of the at least one lead, and receive a user selection from selectable stimulation modes for stimulating the identified one or more lateral spinal neural targets. The electrostimulator can apply electrostimulation energy to the identified one or more lateral spinal neural targets via the at least one lead in accordance with the user selection from the selectable stimulation modes.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
95.
PATIENT FEEDBACK SYSTEM FOR ADJUSTING STIMULATION PARAMETERS
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Moore, Lisa Denise
Hoenes, Benjamin Ray
Abrégé
A system may include a stimulator configured to deliver a DBS therapy according to a first therapy program, and a processing system. The processing system may be configured for use to receive a logged event indicative of an acute reduction in therapy, automatically identify a second therapy program for the DBS therapy to address the acute reduction in therapy, deliver the DBS therapy according to the second therapy program, prompt the user to report whether the user likes or dislikes the DBS therapy delivered according to the second therapy program, and control the DBS therapy based on the report by choosing a third therapy program, reverting to the first therapy program, or continuing to deliver the DBS therapy according to the second therapy program.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
96.
SYSTEMS AND METHODS FOR SELECTING ELECTRODES AND PROVIDING STIMULATION
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Bokil, Hemant
Abrégé
Method and systems are described for identifying electrodes for stimulation of a patient using a stimulation system. The stimulation system includes at least one stimulation lead implanted in a patient and having electrodes disposed thereon. The method includes obtaining a plurality of bioelectrical signals, wherein each of the bioelectrical signals is obtained using a different one, or a different combination, of the electrodes; analyzing a dataset including the bioelectrical signals to identify at least one fundamental component of the dataset, each of the at least one fundamental component identifying a contribution of one or more of the electrodes to the fundamental component; and using at least one of the at least one fundamental component to identify one or more of the electrodes for stimulation according to the contribution of each of the one or more of the electrodes to the at least one of the at least one fundamental component.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
97.
NEUROSTIMULATION CLOSED-LOOP PROGRAMMING RECOMMENDATION SYSTEM
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Mcdonald, Matthew Lee
Hershey, Bradley Lawrence
Bains, Amarpreet Singh
Huynh, Dat Thanh
Harvey, Marcus
Abrégé
Systems aanndd mmeetthhooddss ffoorr generating and implementing customized recommendations as part of closed-loop neurostimulation programming and device configuration approaches are disclosed. In an example, a system is configured to: identify, with a recommendation model (e.g., a closed-loop programming algorithm), a programming setting for use in a neurostimulation device that controls neurostimulation treatment of a patient; communicate, to a patient device (e.g., a patient smartphone), a command to present a recommendation to use the programming setting; and communicate, to the patient device, data values associated with the programming setting, to reconfigure the neurostimulation device according to the programming setting. In various examples, a medical user interface enables a medical user (e.g., clinician) to customize the recommendation, and a patient user interface enables a patient to view and use the recommendation.
G16H 20/30 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies ou des activités physiques, p. ex. la physiothérapie, l’acupression ou les exercices
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
98.
AUTOMATED SELECTION OF ELECTRODES AND STIMULATION PARAMETERS IN A DEEP BRAIN STIMULATION SYSTEM USING OBJECTIVE MEASUREMENTS
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (USA)
Inventeur(s)
Juarez Paz, Leon
Abrégé
A method for optimizing stimulation for a patient having a stimulator device such as a Deep Brain Stimulation (DBS) device is disclosed, which involves a consideration of tissue imaging information in the environment around the lead. Test stimulation is provided at initial combinations of lead positions and values of a stimulation parameter such as amplitude, with patient results scored for each combination. One or more objective criteria are measured and scored. The objective criteria may be electrode impedances and/or indicators of stress, such as cardiac signals. This process repeats iteratively until a stopping criterium is met. The lead positions in question may be longitudinal or rotational positions around the lead, and preferably both if the lead is directional in nature.
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
99.
Filtering Algorithm for Assessing Communications Wirelessly Received by an Implantable Medical Device
Boston Scientific Neuromodulation Corporation (USA)
Inventeur(s)
Kothandaraman, Sridhar
Zottola, Dennis
Abrégé
A filtering algorithm implemented by a filtering module in an implantable medical device (IMD), or in an external device for communicating with an IMD, is disclosed which reviews blocks based on a number of rules. The filtering module preferably comprises both firewall and instruction analysis modules. The instruction analysis module analyzes the instructions and associated data (if present) in each block to determine whether such blocks would compromise operation of the IPG or injure a patient if executed. Instruction rules corresponding to an instruction identified in the block are retrieved by the instruction analysis module. The instruction analysis module reviews the block per the retrieved rules, and possibly also in light of current and historical IPG therapy setting or mode data, or other received but un-executed blocks. If a block is compliant, it is executed by the IMD or transmitted to the IMD.
A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
100.
METHODS AND ABLATION SYSTEMS FOR TREATMENT OF SACROILIAC JOINT PAIN USING SHORT, HIGH VOLTAGE PULSES
A61B 18/00 - Instruments, dispositifs ou procédés chirurgicaux pour transférer des formes non mécaniques d'énergie vers le corps ou à partir de celui-ci